Neuro-Oncology News


Feb 28, 2017
Study finds no evidence of common herpes type virus in aggressive brain cancer tissue
In a rigorous study of tumor tissue collected from 125 patients with aggressive brain cancers, researchers at Johns Hopkins say they have found no evidence of cytomegalovirus infection and conclude that a link between the 2 diseases, as claimed by earlier reports, likely does not exist.
Feb 27, 2017
Molecule stops fatal pediatric brain tumor
Northwestern Medicine scientists have found a molecule that stops the growth of diffuse intrinsic pontine glioma inmice. The study, using a mouse model, is published today in Nature Medicine.
Jan 11, 2017
Tumor-seeking salmonella treats brain tumors
Biomedical engineers at Duke University have recruited Salmonella typhimurium in the fight against glioblastoma. Tests in rat models with extreme cases of the disease showed a remarkable 20% survival rate over 100 days -- roughly equivalent to 10 human years -- with the tumors going into complete remission.
Nov 17, 2016
Study reveals new information about how glioblastoma multiforme spreads
A study by MD Anderson Cancer Center researchers has established that the gene WNT5A is a key factor in glioma stem cells transitioning to GdECs. This opens up the possibility for a new therapeutic strategy for patients with glioblastoma.
Sep 15, 2016
Computer program beats physicians at brain cancer diagnosis
A program developed at Case Western Reserve was nearly twice as accurate as 2 neuroradiologists in determining whether abnormal tissue seen on MRI was radiation necrosis or if brain cancer had returned. The findings could speed identification of recurrent tumors, and eliminate costly and risky brain biopsies.
Mar 14, 2016
Anticancer drug restores hearing in some patients with neurofibromatosis
In a small clinical study with an anticancer drug that halts blood vessel growth, intravenous bevacizumab, a handful of people with neurofibromatosis type 2 and hearing loss had restoration of hearing. Results of the collaborative study were described online March 14, 2016 in the Journal of Clinical Oncology.
Mar 03, 2016
PGK1 protein promotes brain tumor formation and cancer metabolism
PGK1, a glycolytic enzyme, has been found to play a role in coordinating cellular processes crucial to cancer metabolism and brain tumor formation, according to results published in today's online issue of Molecular Cell. The findings may lay the groundwork for improved approaches to diagnosis and treatment of glioblastoma and other cancers.
Feb 19, 2016
Biochemical alteration responsible for brain tumor resistance identified
A team of researchers have observed that the cells in glioblastoma tumors harbor a common intrinsic defect, related to the enzyme endonuclease DFF40/CAD, that prevents them from degrading their genetic material during apoptosis. This lack of degradation and removal of genetic material from malignant cells could have detrimental consequences for the organism, such as new tumor processes, often more aggressive than the original one.
Feb 02, 2016
Study finds significant cognitive impairment in adult survivors of childhood brain tumors
Cancer survivors of childhood brain tumors show significant deficits in intelligence, educational achievement, and employment, even decades after treatment, an unprecedented study at St Jude Children's Research Hospital has found. The study findings were published online in the Journal of Clinical Oncology, and will help guide efforts to prevent and alleviate such problems.
Jan 28, 2016
Multi-center study reveals unique subtypes of most common malignant brain cancer
An international collaborative study has revealed detailed new information about diffuse glioma. More specifically, the study has expanded knowledge of the glioma somatic alteration landscape, emphasized the relevance of DNA methylation profiles as a method for clinical classification, and has linked TERT (telomerase reverse transcriptase) pathway alterations to telomere maintenance.
Next ▶